Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chanelle McCoy, Cannaray First To Pass UK FSA’s CBD Safety Assessment

May 02 2024

• By David Ridley

CBD Molecule — • Source: Shutterstock

Related Content

UK Proposes Accelerating Authorizations Of Novel Supplements Like CBD

Apr 11 2024

UK FSA Admits It Could Have ‘Better Anticipated’ CBD Application Bottleneck

Mar 02 2022

UK Government Narcotics Advisors Recommend 0.05mg THC Limit For CBD Products

Jan 27 2022

Review UK’s ‘Onerous’ CBD Novel Food Process, Says Parliamentary Group

Aug 31 2022

First UK CBD Novel Food Authorizations Not Expected Until 2024 At The Earliest

Apr 05 2023

Additional Topics

United Kingdom Europe Advisory Committees Cannabidiol CBD Consumer Compliance Dietary Supplements Ingredients Legal Issues Market Access Risk Management Safety

More from United Kingdom

More from Europe

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.